Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Elicio Therapeutics Inc banner

Elicio Therapeutics Inc
F:9HA

Watchlist Manager
Elicio Therapeutics Inc Logo
Elicio Therapeutics Inc
F:9HA
Watchlist
Price: 11.4 EUR 1.79% Market Closed
Market Cap: €199.4m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Gross Profit
Loading...
Operating Income
Loading...
Pre-Tax Income
Loading...
Net Income
Loading...

Wall St Price Targets

9HA Price Targets Summary
Elicio Therapeutics Inc

Wall Street analysts forecast 9HA stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 9HA is 11.04 EUR with a low forecast of 10.62 EUR and a high forecast of 11.69 EUR.

9HA Lowest Forecast
10.62 EUR
-7% Downside
9HA Average Forecast
11.04 EUR
-3% Downside
9HA Highest Forecast
11.69 EUR
3% Upside
Lowest Forecast
Price Target
10.62 EUR
7% Downside
Average Forecast
Price Target
11.04 EUR
3% Downside
Highest Forecast
Price Target
11.69 EUR
3% Upside
Elicio Therapeutics Inc Competitors:
Price Targets
S
SITOWS
Sitowise Group Oyj
-12% Downside
S
SITOWS
Sitowise Group Oyj
-12% Downside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Elicio Therapeutics Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Elicio Therapeutics Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-85%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-85%
Average Miss

What are analyst estimates?

See Also

Summary
9HA intrinsic value, competitors valuation, and company profile.
DCF Valuation
9HA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
9HA stock valuation using valuation multiples.
Wall St Estimates
9HA price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
9HA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Elicio Therapeutics Inc listings:
NASDAQ • USD
ELTX
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 9HA's stock price target?
Price Target
11.04 EUR

According to Wall Street analysts, the average 1-year price target for 9HA is 11.04 EUR with a low forecast of 10.62 EUR and a high forecast of 11.69 EUR.

Back to Top
ALPHA SPREAD
Follow us
Join 342,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett